FDA's Marks hopes to align global regulators to boost gene therapy
By Patrick Wingrove PHILADELPHIA (Reuters) - U.S. Food and Drug Administration official Peter Marks said on Wednesday he hopes to align global ...
Stay updated with breaking news from Patrick Wingrove. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Patrick Wingrove PHILADELPHIA (Reuters) - U.S. Food and Drug Administration official Peter Marks said on Wednesday he hopes to align global ...
Amgen's battle with Sanofi and Regeneron at the Supreme Court over its cholesterol drug Repatha on Monday has some drugmakers hoping a ruling will reshape US patent law and competition among companies that make antibody medicines.
Moderna's chief executive on Wednesday defended the company's plan to quadruple the price of its COVID-19 vaccine, telling a US Senate committee hearing it will no longer have the economies of scale from government procurement when the shots move into the private market.
By Patrick Wingrove (Reuters) -Moderna Inc expects to price its COVID-19 vaccine at around $130 per dose in the U.S. going forward as purchases move t...
(Reuters) - Sanofi SA said on Thursday it would cut U.S. list prices by 78% for its most-prescribed insulin product starting next year, following riva...